NCT03441113 2024-05-16
Extended Access of Momelotinib in Adults With Myelofibrosis
GlaxoSmithKline
Phase 2 Active not recruiting
Clinical Trials
1 trialsPrimary Myelofibrosis × N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide × Clear all